Apop presents on further advances with CalRexin™: 647

Join us at ACS (Australasian Cytometry Society Conference) 27-30 August 2023, in Queenstown, New Zealand where our CSO, A/Prof. Peter Wookey, will be presenting the further advances in Apop’s imaging tools for the detection of apoptosis.

Unlike alternatives, CalRexin™: 647 can be used to define subpopulations of cells, including live, apoptotic, transition and dead cell populations using FACS.

“The development of anti-Human Calcitonin Receptor antibodies to track receptor expression in blood diseases and activity in apoptosis using flow cytometry” (Poster abstract B010) will be presented by A/Prof. Peter Wookey.

Previous
Previous

Apop is attending the Bio International Convention in San Diego, June 3-6 2024

Next
Next

Latest advances in Apop’s imaging tools for apoptosis